Related Experiment Videos
Comparison of two triphasic oral contraceptives containing either gestodene or norethindrone: a randomized,
F Weber-Diehl1, J Lehnert, U Lachnit
1Department of Fertility Control, Schering AG, Berlin, Germany.
Contraception
|October 1, 1993
Abstract:
Two triphasic oral contraceptives containing either gestodene or norethindrone as the progestogenic compound combined with ethinyl estradiol were compared in a randomized clinical trial to assess their contraceptive reliability, clinical tolerance and cycle control. Both preparations were effective in preventing pregnancy. The gestodene preparation proved significantly superior regarding cycle control and general tolerance.
Keywords:
BiologyBlood PressureBody WeightClinical ResearchClinical TrialsComparative StudiesContraceptionContraceptive Agents, EstrogenContraceptive Agents, Female--side effectsContraceptive Agents, Progestin--side effectsContraceptive Agents--side effectsContraceptive EffectivenessContraceptive Methods--administraction and dosageContraceptive Methods--side effectsDeveloped CountriesDiseasesDropoutsEthinyl EstradiolEuropeFamily PlanningFamily Planning ProgramsGermanyGestodene--side effectsHemic SystemMenstruation DisordersNorethindrone--side effectsOral Contraceptives, Combined--administraction and dosageOral Contraceptives, Combined--side effectsOral Contraceptives, Phasic--administraction and dosageOral Contraceptives, Phasic--side effectsOral Contraceptives--administraction and dosageOral Contraceptives--side effectsPhysiologyProspective StudiesResearch MethodologyStudiesWestern Europe